姓名:严彦
职称: 副研究员
电话: 0756-2526140,13823000497
电子邮件: yanyan35@mail.sysu.edu.cn
通讯地址: 珠海市香洲区梅华东路52号,中山大学附属第五医院
学历和工作经历
2017/08-至今,中山大学,附属第五医院,副研究员
2016/07-2017/07,新加坡国立大学,资深博士后
2012/02-2016/06,新加坡国立大学,博士后
2006/01-2011/11,南洋理工大学(新加坡),博士
研究方向
1. 海洋天然产物药理、 类器官与药物筛选
2. 基于AI的病理-药理-组学分析与靶点发现
3. 微生物菌群与肿瘤
4. Hippo信号通路
承担科研项目情况
在研科研项目:
1. 广东省特支计划青年拔尖人才揭榜挂帅项目,基于fMRI、TRP通路以及人工智能的抗抑郁精准用药体系建立研究,榜单编号TZ09B0006,参与
已完成科研项目:
1. 国家自然科学基金,面上项目,82170029,肺泡II型上皮细胞YAP/TGFβ2/CTGF通路参与哮喘终末气道纤维化的作用机制研究,主持
2. 国家自然科学基金,面上项目,81870019 ,CD151在鼻病毒诱导型哮喘气道重塑中的作用及分子机制研究,主持
3. 广东省自然科学基金,自由申请项目,2018A030313554 ,RV16鼻病毒感染气道上皮细胞激活成纤维细胞的分子机制及其在慢性气道炎症疾病中的病理作用研究,主持
4. 中山大学“百人计划”科研启动项目,免疫学,主持
5. 广州市产学研协同创新重大专项民生科技研究,TSLP-Hippo/YAP通路介导成纤维细胞转分化在重症哮喘气道重塑中的作用,参与
6. 珠海市引进高层次卫生团队研究项目,慢性肝脏疾病的基础与临床创新研究团队(二类团队),病毒性肝炎和脂肪肝炎致癌的分子机制研究,参与
代表性成果
近期代表性文章
1. Yichen Luo#, Yanhong Han#, Huilong Nie#, Minghao Feng#, Cuiting Wei, Xiuling Ma, Kefeng Li, Zhuangzhuang Zhang, Guangxue Wang, Wenjun Pan, Xueyang Li, Liutong Yi, De-Yun Wang, Xiantao Zeng, Yongkang Qiao*, Yan Yan*, Yujing Lin*. Tyrosine Hydroxylase as a Therapeutic Target: Insights from Adrenergic Nerve and TNBC Cell Interactions. Journal of Molecular Medicine 2026, 104:53
2. Zixuan Liu, Yuanyuan Shi, Disheng Zhou, Shuna Chen, Xueqi Liu, Yuting Huang, Ziyi Yang, Yanting Liang, Mini Huang, Yan Yan, Yongkang Qiao, Ying Ma, Liu Huan, Lin Qi, Miao Li*, Sze-Hoi Chen*, Xing-Ding Zhang*. Role of MED15 in Enhancing EMT and Metastasis in Bladder Cancer through YAP1 Stabilization. FASEB J 2026 Feb 28;40(4):e71558.
3. Xiuting Huang#, Yuan Zhuang#, Rui Wang#, Jing Qu#, Yuanyang Tan#, Liang Li, Wenjun Pan, Huilong Nie, Kefeng Li, Yujing Lin, Liutong Yi, Xiaoyu Feng, Huiming Lan, Guangxue Wang, Xiantao Zeng, Zhenqi Jiang, De-Yun Wang*, Yongkang Qiao*, Yan Yan*. Colonization by Porphyromonas gingivalis in Cervical Squamous Cell Carcinomas Promotes Metastasis through FimA/CD151/ITGB1 Signaling. Journal of Translational Medicine 2025 23:1166.
4. Yichen Luo, Xiuting Huang, Rui Wang, Yujing Lin, Jiaxin Sun, Kefeng Li, De-Yun Wang, Yan Yan, Yongkang Qiao*. Advancements in understanding tumor-resident bacteria and their application in cancer therapy. Military Medical Research 2025 Jul 25;12(1):38.(review)
5. Junjun Ji, Zhifan Li, Abao Xing, Gang Luo, Xiaobing Zhai, Wei Xu, Junrong Li, Tao Tan, Ruihong Jia, Yan Yan, Xianbin Zhang, Long Wang, Junfeng Li, Kefeng Li*. Causal Relationships Between Alzheimer's Disease Genetics and Brain Connectivity Alterations: A Multi-modal Mendelian Randomization Study with Transcriptomic Validation of 191 rs-fMRI and 635 DTI Neuroimaging Traits. Brain Imaging and Behavior 2026 (in press)
6. Shuya Ren#, Yanhong Han#, Yan Yan, Yuran Zhou, Siwen Yuan, Junjie Chen, Heng Guo, Zhenjian Lin, Qifeng Lin, Senhua Chen, Lan Liu, Yongkang Qiao*, Zhizeng Gao*. Two Novel Peniphenone Derivatives with Distinct Stereoconfigurations from Ascidian-Derived Fungus Diaporthe sp. SYSU-MS4722 and Their Anti-Fibrotic Activities. Journal of Ocean University of China 2026, (25)3:1-7
7. Shuya Ren#, Yan Yan#, Yuran Zhou#, Yanhong Han, Siwen Yuan, Junjie Chen, Heng Guo, Zhenjian Lin, Qifeng Lin, Senhua Chen, Lan Liu, Yongkang Qiao*, Zhizeng Gao*. Genome Mining of Nonenzymatic ortho-Quinone Methide Based Pseudonatural Products from Ascidian-Derived Fungus Diaporthe sp.SYSU-MS4722. Bioorganic Chemistry 2025,154:108081.
8. Siwen Yuan#, Shitao Zhuang#, Yanhong Han, Yuhang Wen, Senhua Chen, Lan Liu, Qifeng Lin, Yan Yan*, Zhizeng Gao*, Qilin Wu*. Genome Mining of Monoterpenes from Ascidian-Derived fungus Diaporthe sp. SYSU-MS4722. Frontiers in Microbiology 2025, 16:1593027.
9. Siwen Yuan#, Shitao Zhuang#, Yongkang Qiao#, Qilin Wu, Yutong Ma, Senhua Chen, Lan Liu, Yan Yan*, Zhizeng Gao*. Metabolic Shunting in Marine-Derived Diaporthe sp. SYSU-MS4722 Yields Diverse γ-Butyrolactone Derivatives with Anti-Inflammatory Activity. Journal of Natural Products 2025 Jul 25;88(7):1605-1615
10. Meiting Ma, Zhengqi Chu, Hongyu Quan, Hanxu Li, Yuran Zhou, Yanhong Han, Kefeng Li, Wenjun Pan, De-Yun Wang, Yan Yan, Zunpeng Shu, Yongkang Qiao*. Natural products for anti-fibrotic therapy in idiopathic pulmonary fibrosis: marine and terrestrial insights. Frontiers in Pharmacology 2025, 16:1524654. (review)
11. Yuyang Sha#, Meiting Jiang#, Gang Luo#, Weiyu Meng, Xiaobing Zhai, Hongxin Pan, Junrong Li, Yan Yan, Yongkang Qiao*, Wenzhi Yang*, Kefeng Li*. HerbMet: A Framework for Chinese Herbal Medicine Identification via Deep Learning and Metabolomics Data. Phytochemical Analysis 2025 Jan;36(1):261-272.
12. Yanrong Guo#, Yuran Zhou#, Rui Wang, Yujing Lin, Huimin Lan, Yang Li, De-Yun Wang, Jinrui Dong, Kefeng Li, Yan Yan*, Yongkang Qiao*. YAP as a potential therapeutic target for myofibroblast formation in asthma. Respiratory Research 2025, 26(1):51.
13. Yuanyang Tan#, Huiqin Zhou#, Yujing Lin#, Liutong Yi#, Zhuanggui Chen, Qingdong Cao, Yanrong Guo, Zhaoni Wang, Shoudeng Chen, Yang Li, De-Yun Wang, Yong-Kang Qiao*, Yan Yan*. FGF2 is overexpressed in asthma and promotes airway inflammation through FGFR/MAPK/NF-κB pathway in airway epithelial cells. Military Medical Research, 2022, 9:7
14. Guihua Zhong#, Wei Wei#, Wei Liao#, Rong Wang, Yingpeng Peng, Yuling Zhou, Xiaotao Huang, Shiping Xian, Shunli Peng, Zhaoyuan Zhang, Shaoyan Feng, Ye Liu, Haiyu Hong, Yunfei Xia, Yan Yan*, Qiaodan Liu*, Zhigang Liu*. Tumor microbiome in nasopharyngeal carcinoma and its association with prognosis. Frontiers in Oncology, 2022 May 23;12:859721.
15. Haiyu Hong#, Kai Sen Tan#, Yan Yan#, Fenghong Chen#, Hsiao Hui Ong, Yukei Oo, Jing Liu, Yew Kwong Ong, Mark Thong, Richard Sugrue, Vincent T Chow*, De-Yun Wang*. Induction of IL-25 Expression in Human Nasal Polyp Epithelium by Influenza Virus Infection is Abated by Interferon-Alpha Pretreatment. Journal of Inflammation Research, 2021.14:2769-2780
16. Yuanyang Tan#, Yongkang Qiao#, Zhuanggui Chen, Jing Liu, Yanrong Guo, Thai Tran, Kai Sen Tan, De-Yun Wang*, Yan Yan*. FGF2, an immunomodulatory factor in asthma and chronic obstructive pulmonary disease (COPD). Frontiers in Cell and Developmental Biology, 2020,8:223.(review)
17. Zhaoni Wang#, Ruonan Su#, Biyun Yang, Kexin Yang, Lifen Yang, Yan Yan*, Zhuanggui Chen*.Potential role of cellular senescence in asthma. Frontiers in Cell and Developmental Biology, 2020,8:59. (review)
18. Yanrong Guo#, Qingdong Cao#, Zhongsi Hong#, Yuanyang Tan, Shoudeng Chen, Hongjun Jin, Kai Sen Tan, De-Yun Wang*, Yan Yan*. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Military Medial Research, 2020,7(1):11. (review)
19. Sisi Kang, Mei Yang, Zhongsi Hong, Liping Zhang, Zhaoxia Huang, Xiaoxue Chen, Suhua He, Ziliang Zhou, Zhechong Zhou, Qiuyue Chen, Yan Yan, Changsheng Zhang, Hong Shan*, Shoudeng Chen*. Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potental unique drug targeting sites. Acta Pharm Sin B, 2020. 10(7):1228-1238
20. Yongkang Qiao#, Yan Yan#, Kai Sen Tan#, Sheryl SL Tan#, Ju Ee Seet, Thiruma Valavan Arumugam, Vincent T Chow, De-Yun Wang *, Thai Tran*. CD151, a novel host factor of nuclear export signaling in influenza virus infection. Journal of Allergy and Clinical Immunology 2018. 141(5), 1799-1817.
21. Yan Yan#, Kai Sen Tan#, Chunwei Li, Thai Tran, Siew Shuen Chao, Richard J Sugrue, Li Shi, Vincent T Chow *, De-Yun Wang *. Human nasal epithelial cells derived from multiple individuals exhibit differential responses to H3N2 influenza virus infection in vitro. Journal of Allergy and Clinical Immunology 2016,138(1):276-281.
近期代表性专利
1.发明专利,一种聚酮化合物及其在制备抗肺纤维化的药物中的应用, ZL20241023000.5,发明人:骆奕辰,周昱然,王锐,严彦,高志增,任淑雅
2.实用新型专利,自然腔道上皮组织细胞收集装置, ZL202323058373.8,发明人:骆奕辰,林宇静,严彦,兰慧敏
3.发明专利,一种聚酮类二聚体化合物及其在制备抗肺纤维化的药物中的应用,申请号2024102351913(实审中),发明人:严彦,骆奕辰,周昱然,高志增,任淑雅
4.发明专利,一种预测三阴性乳腺癌顺铂药物敏感性的标志物及其应用,申请号2024105530296(实审中),发明人:骆奕辰,严彦,林宇静,聂惠龙,魏崔婷,刘彦君,董杰
5.发明专利,一种肿瘤-神经细胞互作模型,申请号2024108472841(实审中),发明人:骆奕辰,严彦,魏崔婷,刘彦君,姚逸凡,庄诗涛,王哲彦
获奖及荣誉
2023年:Military Medical Research期刊2020-2023年度杰出贡献(高被引论文)奖
2021年:珠海市高层次人才(三类)
2021年:中大五院2020-2021年度优秀科技工作者
2019年:广东省杰出青年医学人才
2017年:中山大学“百人计划二期”引进人才